What is Rett syndrome—and how close are we to effective treatments? In this episode of Neuroscience Perspectives, Dr. John Foxe, director of the Del Monte Institute for Neuroscience at University of Rochester Medicine, sits down with Dr. Jeffrey Neul, a leading expert in pediatric neurology and neurodevelopmental disorders, to explore the latest breakthroughs in Rett syndrome research, clinical trials, and biomarker development. Rett syndrome is a rare genetic neurological disorder that primarily affects girls and is often caused by mutations in the MECP2 gene. Dr. Neul shares how advances in neurogenetics and translational neuroscience are transforming how researchers understand and treat this complex condition. #RettSyndrome #Neuroscience #RareDisease #PediatricNeurology #BrainResearch #Neurodevelopment #ClinicalTrials #MedicalResearch #SciencePodcast #Podcast

🧠Stay Connected

Subscribe: https://www.youtube.com/@URNeuroscience

X: https://x.com/URNeuroscience

BlueSky: https://bsky.app/profile/urneuroscience.bsky.social

LinkedIn: https://www.linkedin.com/company/urneuroscience/

🧠Experts in this Episode:

Jeffrey Neul, MD, PhD: https://vkc.vumc.org/people/neul-jeffrey

John Foxe, PhD: https://www.urmc.rochester.edu/people/112360965-john-j-foxe

🧠Labs Mentioned:

Neul Lab: http://neullab.com/index.html

Frederick J. and Marion A. Schindler Cognitive Neurophysiology Lab: https://urmc.info/1RG